Avidia

company

About

Avidia is a biopharmaceutical company engaged in discovering and developing therapeutic proteins.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$43.80M
Industries
Biotechnology,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Active

Avidia, Inc., a biopharmaceutical company, engages in discovering and developing therapeutic proteins. The company offers Avimer therapeutic proteins, which are used to address various therapeutic areas, including autoimmunity, inflammation, oncology, and neurology. Avidia, Inc. was founded in 2003 and is headquartered in Mountain View, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$43.80M
Avidia has raised a total of $43.80M in funding over 2 rounds. Their latest funding was raised on May 9, 2006 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 9, 2006 Series C $43.80M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Avidia is funded by 1 investors. TPG are the most recent investors.
Investor Name Lead Investor Funding Round
TPG Series C